Skip to main content
Equibles

INDSWFTLAB · Ind-Swift Laboratories Limited · Documents

Use INDSWFTLAB with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research INDSWFTLAB.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
361.30 INR +0.95 (+0.26%) At close · Nov 13
Rebalance outlook locked
Market Cap
31.42B INR
Shares
86.96M
Volume · Nov 13 328.11K Avg daily vol (3M) 926.25K

The company's reports, filings, earnings calls and investor events, most recent first. Search these from Claude or ChatGPT →

Earnings call Q2 2027 earnings call Held Nov 4, 2026
2026
Nov 4
Earnings call
Q2 revenue rises 50.15%, PAT surges 3.54x

Ind-Swift Laboratories Limited reported Q2 FY27 operating revenue of ₹234.89 crore, up 50.15% year-on-year, and PAT of ₹31.03 crore, up 3.54x. Management reiterated FY27 guidance for more than 50% revenue growth.

4 source passages
Ind-Swift Laboratories Q2 and H1 FY27 Earnings Conference Call. Operating Revenue stood at ₹234.89 crore, up 50.15% year-on-year from ₹156.43 crore, and expanding 26.22% quarter-on-quarter from ₹186.09 crore in Q1 FY27. PAT surged 3.54x year-on-year and 26.96% quarter-on-quarter to ₹31.03 crore, delivering a PAT margin of 13.21%, up 761 bps year-on-year. We reiterate our full-year guidance of more than 50% revenue growth in FY27. Open the document at this passage
Showing 1–2 of 2 documents